» Articles » PMID: 26714388

Relationship of Normalized Protein Catabolic Rate with Nutrition Status and Long-Term Survival in Peritoneal Dialysis Patients

Overview
Journal Adv Perit Dial
Date 2015 Dec 31
PMID 26714388
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

The normalized protein catabolic rate (nPCR) reflects daily dietary protein intake in stable dialysis patients. In peritoneal dialysis (PD) patients, reports about the importance of nPCR as marker of nutrition and outcome have been inconsistent. The objective of the present study was to investigate the relationships of nPCR with body composition parameters, micronutrient electrolytes, and long-term survival in PD patients. From November 2000 to May 2008, 57 PD patients were enrolled in the study. On enrollment, demographic, clinical, and biochemical data were recorded. Patients were followed through September 2011. Mean age of the patients was 56 years, and 61% were of African descent. Mean and maximum follow-up were 2.83 years and 11 years respectively. Mean daily nPCR was 0.944 g/kg. The nPCR correlated directly with albumin (r = 0.34, p = 0.012), magnesium (r = 0.48, p < 0.0001), phosphorus (r = 0.42, p = 0.02), and the phase angle body composition parameter (r = 0.26, p = 0.049). Compared with patients whose enrollment daily nPCR was less than 0.8 g/kg, those with an enrollment daily nPCR of 0.8 g/kg or more experienced significantly better 11-year cumulative survival (p = 0.04). In multivariate Cox regression analysis with adjustment for confounding variables, nPCR was an independent predictor of all-cause mortality (p = 0.018). In conclusion, lower nPCR is associated with poorer nutrition status and increased risk of all-cause mortality in PD patients followed for up to 11 years.

Citing Articles

The Role of Kt/V and Creatinine clearance on Assisting Optimization of Serum Phosphorus Levels among Patients on PD.

Uribarri J, Guedes M, Diaz Bessone M, Chan L, De La Torre A, Mermelstein A Kidney360. 2024; .

PMID: 39450995 PMC: 11793178. DOI: 10.34067/KID.0000000618.


Cognitive Dysfunction Screening in Peritoneal Dialysis Patients: A Cross-Sectional Study.

Bras A, Marques J, Fernandes V, Ferreira A Indian J Nephrol. 2024; 34(4):357-362.

PMID: 39156843 PMC: 11326789. DOI: 10.25259/ijn_378_23.


Creatinine index as a predictive marker of sarcopenia in patients under hemodialysis.

Plytzanopoulou P, Politis P, Papachrysanthou T, Andriopoulos C, Drakou A, Papachristou E Int Urol Nephrol. 2021; 54(7):1565-1573.

PMID: 34674147 DOI: 10.1007/s11255-021-03032-0.


Changes in plasma sclerostin level associated with use of a medium cut-off dialyzer in end-stage renal disease.

Ahn S, Ko M, Song J, Jung J Kidney Res Clin Pract. 2021; 40(1):120-134.

PMID: 33745263 PMC: 8041631. DOI: 10.23876/j.krcp.20.173.


Effects of online hemodiafiltration on anemia and nutritional status in chronic hemodialysis patients.

Lee Y, Shin Y, Lee S, Kim Y, Lee S, Moon J Kidney Res Clin Pract. 2020; 39(1):103-111.

PMID: 32036641 PMC: 7105619. DOI: 10.23876/j.krcp.19.082.